Rishabh Nagori

The Hidden Growth Killer When guidelines don’t translate to prescriptions — brands silently lose ground. A leading Amox-Clav brand was losing share in paediatric pneumonia despite being fully aligned with IAP and WHO guidelines. Doctors knew the science — yet chose cephalosporins. Why? Convenience bias. Dosing uncertainty. Pharma nudging. Lack of follow-up systems. This is therapy drift — the silent growth killer in pharma. We helped the brand turn it around through academy-endorsed CME tools, clinic-integrated patient education, and automated follow-ups. The outcome: realigned prescriptions, stronger brand leadership, and measurable growth. #PharmaMarketing #TherapyDrift #BrandGrowth #DoctorEngagement

6

Mave Health raises $2.1M led by Blume Ventures to scale its neurotech-driven D2C wellness brand. With strong early traction, global expansion plans, and science-backed innovation, the startup is emerging as a fast-growing player in India’s evolving D2C ecosystem, blending deeptech with consumer-focused health and performance solutions.#pulsedaily Read more: https://lnkd.in/gBngemdq Abhishek Shah Dhawal Jain Jai Sharma Aman Kumar

9

Excited to have been part of a truly insightful discussion at ET Edge 40 Under 40 – North Edition 2025! The theme, 'Passion vs. Precision: Being Human in the Age of AI,' resonated deeply with our work at HexaHealth. It's a critical conversation today for healthcare and beyond, exploring the evolving role of emotion, empathy, and human instinct in an AI-driven world. As Ginni Rometty, former CEO of IBM, wisely said, "AI will not replace humans, but those who use AI will replace those who don't." This perfectly encapsulates the current scenario: AI is an undeniable force, rapidly transforming how we live and work. For HexaHealth, it's about harnessing this precision to augment human passion – empowering our healthcare experts to deliver more empathetic, personalised care by streamlining the complexities that often stand in the way. Looking ahead, I'm incredibly optimistic about the future that we can create. By building a culture where our data scientists and healthcare professionals collaborate openly, and by consistently prioritizing the human side of care, we can ensure AI serves humanity's best interests. It's about a future where technology amplifies our capacity for connection, understanding, and healing. A big thank you to my fellow panelist Neha Sinha, Founder & CEO, Epoch Elder Care, and our fantastic moderator Sriram Vijayaraghavan, Director, PwC India, for a powerful trilogue! #ETEdge40Under40 #40U40North2025 #ETEdge40U40 #FutureFrontier #WhereVisionMeetsImpact #AIinHealthcare #PassionVsPrecision #HumanityInAI #HexaHealth

89

3 Comments

Takeaways from Learning Product Market Fit [PMF] in Public (literally 😛 ) with Sajith Pai 1. PMF: Investor-first view of a business. Simply put, PMF from an operator/founder pov is Growth+Retention+Unit Economics [GRUE] 2. Best businesses: Have zero marginal cost of getting new users (network effect) +  zero marginal cost of servicing new user. Very few exist 3. Great businesses: Have zero marginal cost of servicing new users but an extra cost of getting each new user. Hence, most good businesses come down to distribution efficiency. 4. PMF = Strong Customer Love + Efficient Distribution Systems 5. PMF is easier to define for B2B than for B2C. In his words, B2B is logic while B2C is magic! 3. For infrequent use case products, use the ICED framework by Vivek Kumar 4. The space you pick has an outsized impact on the effort it may take to PMF. It's like picking a game - once you choose, the rules & constraints of that will apply Thank you Sakshi for hosting this! Link to all articles of Sajith on PMF is in first comment. ------- #Learning-in-public-#3 I am learning-in-Public on Brand Building, Content, and PMF. Do point me to any top resources & people on these topics.

31

3 Comments

Is India ready for a subscription-first wearable like WHOOP? How is India adopting WHOOP? WHOOP’s approach is very different from most wearables. No screen. No step counts. Just recovery, sleep, and performance insights. Globally, it’s built credibility by going elite-first athletes, high-performers, serious fitness communities. In India, adoption is still early and selective. What I’m noticing: • Mostly early adopters & fitness enthusiasts • Growing curiosity around subscription-based health insights • Still seen as premium + niche, not mass-market WHOOP isn’t trying to win India on price or features it’s betting on mindset shift: from “tracking activity” to optimising recovery. My take: India is curious, but still deciding if WHOOP is a need or a nice-to-have.

4

🚀 Zepto × DPIIT | Powering India’s Next-Gen Manufacturers Quick-commerce giant Zepto, in collaboration with DPIIT, has launched its innovation program “Zepto Nova”, selecting 8 promising Indian startups for its first cohort (launched on Jan 20, 2026). 🎯 What Zepto Nova Offers ✅ Market access through Zepto’s quick-commerce network ✅ Brand visibility at scale ✅ End-to-end logistics support ✅ Focus on early-stage Indian manufacturers 🏆 Selected Startups (Cohort 1): • Milleto Nutto – Food & Beverages • Aloe Ecell – Sustainable energy (Aloe-vera-based battery tech) • Flavours of Calicut – Keralite snacks • Thy Chocolate – Bean-to-bar chocolates • No Cap Foods – Scalable consumer brand • Nesta Toys – Toys & learning • Watch Out – Toys & learning • Makerverse – Niche consumer innovation 📊 Selected from 49 applications after a rigorous evaluation & final pitch round. 🌱 Strong presence of women-led and first-generation founders. 📅 Cohort 2 launching in February 2026 This initiative highlights how corporate–government collaboration can unlock real growth for Indian startups and manufacturers. 📞 For guidance on DPIIT recognition, Startup India benefits, incubation programs & government funding: Ankush Verma Startup & IPR Consultant 📱 7014264283 #ZeptoNova #StartupIndia #DPIIT #IndianStartups #ManufacturingStartups #Innovation #QuickCommerce #StartupEcosystem

15